Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 739

1.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2018 Jun 26. doi: 10.1093/annonc/mdy207. [Epub ahead of print] No abstract available.

PMID:
29947731
2.

Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.

Baron F, Stevens-Kroef M, Kicinski M, Meloni G, Muus P, Marie JP, Halkes CJM, Thomas X, Vrhovac R, Specchia G, Lefrere F Sr, Sica S, Mancini M, Venditti A, Hagemeijer A, Becker H, Jansen JH, Amadori S, de Witte T, Willemze R, Suciu S.

Ann Hematol. 2018 Jun 20. doi: 10.1007/s00277-018-3396-4. [Epub ahead of print]

PMID:
29926156
3.

Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M; ESMO Guidelines Committee.

Ann Oncol. 2018 Jun 6. doi: 10.1093/annonc/mdy133. [Epub ahead of print] No abstract available.

PMID:
29878045
4.

Mycosis fungoides variants-clinicopathologic features, differential diagnosis, and treatment.

Willemze R.

Semin Cutan Med Surg. 2018 Mar;37(1):11-17. doi: 10.12788/j.sder.2018.004.

PMID:
29719015
5.

The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study.

Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, DiCaudo DJ, Shinohara M, Hong EK, Horton B, Kim YH.

Am J Surg Pathol. 2018 Jun;42(6):726-734. doi: 10.1097/PAS.0000000000001041.

PMID:
29543675
6.

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP.

Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7. No abstract available.

PMID:
29514783
7.

Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.

Melchers RC, Willemze R, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Vermeer MH, Quint KD.

Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16501. [Epub ahead of print]

PMID:
29494757
8.

β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case-control study.

Willemze RA, Bakker T, Pippias M, Ponsioen CY, de Jonge WJ.

Eur J Gastroenterol Hepatol. 2018 Feb;30(2):161-166. doi: 10.1097/MEG.0000000000001016.

PMID:
29111997
9.

Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long-term follow-up data in a series of 9 cases.

van Santen S, Jansen PM, Vermeer MH, Willemze R.

J Cutan Pathol. 2018 Feb;45(2):122-128. doi: 10.1111/cup.13077. Epub 2017 Dec 11.

PMID:
29086994
10.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2017 Oct 1;28(10):2517-2525. doi: 10.1093/annonc/mdx352.

PMID:
28961843
11.

Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.

Melchers RC, Willemze R, Daniëls LA, Neelis KJ, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Velstra B, Veraart JCJM, Roach REJ, Vermeer MH, Quint KD.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1279-1285. doi: 10.1016/j.ijrobp.2017.08.010. Epub 2017 Aug 24.

PMID:
28958772
12.

Neuronal control of experimental colitis occurs via sympathetic intestinal innervation.

Willemze RA, Welting O, van Hamersveld HP, Meijer SL, Folgering JHA, Darwinkel H, Witherington J, Sridhar A, Vervoordeldonk MJ, Seppen J, de Jonge WJ.

Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13163. Epub 2017 Jul 26.

PMID:
28745812
13.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

14.

Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.

van Santen S, van Doorn R, Neelis KJ, Daniëls LA, Horváth B, Bruijn MS, Sanders CJG, van Rossum MM, de Haas ERM, Veraart JCJM, Bekkenk MW, Vermeer MH, Willemze R.

Br J Dermatol. 2017 Jul;177(1):223-228. doi: 10.1111/bjd.15355. Epub 2017 May 11.

PMID:
28132406
15.

Cutaneous lymphomas with a panniculitic presentation.

Willemze R.

Semin Diagn Pathol. 2017 Jan;34(1):36-43. doi: 10.1053/j.semdp.2016.11.009. Epub 2016 Nov 29. Review.

PMID:
27986433
16.

Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.

Boonk SE, Zoutman WH, Putter H, Ram-Wolff C, Felcht M, Klemke CD, Ranki A, Quaglino P, Whittaker S, Bagot M, Willemze R, Vermeer MH.

J Invest Dermatol. 2017 Mar;137(3):754-757. doi: 10.1016/j.jid.2016.10.025. Epub 2016 Oct 28. No abstract available.

17.

Acetylcholine-producing T cells in the intestine regulate antimicrobial peptide expression and microbial diversity.

Dhawan S, De Palma G, Willemze RA, Hilbers FW, Verseijden C, Luyer MD, Nuding S, Wehkamp J, Souwer Y, de Jong EC, Seppen J, van den Wijngaard RM, Wehner S, Verdu E, Bercik P, de Jonge WJ.

Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G920-G933. doi: 10.1152/ajpgi.00114.2016. Epub 2016 Aug 11.

18.

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial.

Selleslag D, Suciu S, Meloni G, Muus P, Halkes CJ, Venditti A, Ramadan SM, Pruijt H, Meert L, Vignetti M, Marie JP, Wittnebel S, de Witte T, Amadori S, Willemze R, Baron F.

Haematologica. 2017 Feb;102(2):e47-e51. doi: 10.3324/haematol.2016.153130. Epub 2016 Oct 27. No abstract available.

19.

p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.

Genders RE, Beck S, Bouwes Bavinck JN, van den Munckhof HA, Kouwenhoven ST, de Koning MN, de Gruijl FR, Jenkins D, Willemze R, Quint KD.

J Cutan Pathol. 2017 Jan;44(1):28-33. doi: 10.1111/cup.12840. Epub 2016 Oct 25.

PMID:
27717097
20.

The clinical spectrum of mycosis fungoides in Tanzania, East Africa.

Grijsen ML, Mtayangulwa RG, Naafs B, Jansen P, Vermeer MH, Mavura D, Masenga EJ, Willemze R.

Br J Dermatol. 2017 Jun;176(6):1653-1656. doi: 10.1111/bjd.14963. Epub 2017 Mar 28. No abstract available.

PMID:
27529394
21.

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.

Versluis J, In 't Hout FE, Devillier R, van Putten WL, Manz MG, Vekemans MC, Legdeur MC, Passweg JR, Maertens J, Kuball J, Biemond BJ, Valk PJ, van der Reijden BA, Meloni G, Schouten HC, Vellenga E, Pabst T, Willemze R, Löwenberg B, Ossenkoppele G, Baron F, Huls G, Cornelissen JJ.

Leukemia. 2017 Jan;31(1):26-33. doi: 10.1038/leu.2016.183. Epub 2016 Jun 24.

PMID:
27416910
22.

Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.

van Santen S, Roach RE, van Doorn R, Horváth B, Bruijn MS, Sanders CJ, de Pooter JC, van Rossum MM, de Haas ER, Veraart JC, Bekkenk MW, Vermeer MH, Willemze R.

JAMA Dermatol. 2016 Sep 1;152(9):992-1000. doi: 10.1001/jamadermatol.2016.1597.

PMID:
27276223
23.

TOX expression in cutaneous B-cell lymphomas.

Schrader AM, Jansen PM, Willemze R.

Arch Dermatol Res. 2016 Aug;308(6):423-7. doi: 10.1007/s00403-016-1654-7. Epub 2016 May 14.

24.

No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course.

Schrader AM, Chung YY, Jansen PM, Szuhai K, Bastidas Torres AN, Tensen CP, Willemze R.

Blood. 2016 Jul 7;128(1):141-3. doi: 10.1182/blood-2016-02-694455. Epub 2016 May 4. No abstract available.

25.

Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers.

van Doorn R, Slieker RC, Boonk SE, Zoutman WH, Goeman JJ, Bagot M, Michel L, Tensen CP, Willemze R, Heijmans BT, Vermeer MH.

J Invest Dermatol. 2016 Sep;136(9):1876-84. doi: 10.1016/j.jid.2016.03.042. Epub 2016 Apr 23. Review.

26.

TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+)  CD8(-) phenotype.

Schrader AM, Jansen PM, Willemze R.

Br J Dermatol. 2016 Aug;175(2):382-6. doi: 10.1111/bjd.14508. Epub 2016 Jun 29.

PMID:
26931394
27.

Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.

Boonk SE, Zoutman WH, Marie-Cardine A, van der Fits L, Out-Luiting JJ, Mitchell TJ, Tosi I, Morris SL, Moriarty B, Booken N, Felcht M, Quaglino P, Ponti R, Barberio E, Ram-Wolff C, Jäntti K, Ranki A, Bernengo MG, Klemke CD, Bensussan A, Michel L, Whittaker S, Bagot M, Tensen CP, Willemze R, Vermeer MH.

J Invest Dermatol. 2016 Jul;136(7):1364-1372. doi: 10.1016/j.jid.2016.01.038. Epub 2016 Feb 28.

28.

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial.

Amadori S, Suciu S, Selleslag D, Aversa F, Gaidano G, Musso M, Annino L, Venditti A, Voso MT, Mazzone C, Magro D, De Fabritiis P, Muus P, Alimena G, Mancini M, Hagemeijer A, Paoloni F, Vignetti M, Fazi P, Meert L, Ramadan SM, Willemze R, de Witte T, Baron F.

J Clin Oncol. 2016 Mar 20;34(9):972-9. doi: 10.1200/JCO.2015.64.0060. Epub 2016 Jan 25.

29.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

30.

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).

de Witte T, Suciu S, Meert L, Halkes C, Selleslag D, Bron D, Amadori S, Willemze R, Muus P, Baron F.

Ann Hematol. 2015 Dec;94(12):1981-9. doi: 10.1007/s00277-015-2486-9. Epub 2015 Sep 26.

31.

Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.

Bruijn MS, Horváth B, van Voorst Vader PC, Willemze R, Vermeer MH.

Br J Dermatol. 2015 Nov;173(5):1319-22. doi: 10.1111/bjd.13920. Epub 2015 Oct 8. No abstract available.

PMID:
25998985
32.

Neural reflex pathways in intestinal inflammation: hypotheses to viable therapy.

Willemze RA, Luyer MD, Buurman WA, de Jonge WJ.

Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):353-62. doi: 10.1038/nrgastro.2015.56. Epub 2015 May 12. Review.

PMID:
25963513
33.

Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.

Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, Géraud C, Kempf W, Assaf C, Ortonne N, Battistella M, Bagot M, Knobler R, Quaglino P, Arheiliger B, Santucci M, Jansen P, Vermeer MH, Willemze R.

Br J Dermatol. 2015 Jul;173(1):93-105. doi: 10.1111/bjd.13832. Epub 2015 Jun 23.

34.

Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.

Boonk SE, Çetinözman F, Vermeer MH, Jansen PM, Willemze R.

J Cutan Pathol. 2015 Sep;42(9):604-9. doi: 10.1111/cup.12490. Epub 2015 May 6.

PMID:
25777533
35.

Limited effect of chemotherapy in cutaneous lymphoma.

Vermeer MH, Willemze R.

Blood. 2015 Jan 1;125(1):4-5. doi: 10.1182/blood-2014-11-609305. No abstract available.

36.

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.

Hengeveld M, Suciu S, Chelgoum Y, Marie JP, Muus P, Lefrère F, Mandelli F, Pane F, Amadori S, Fioritoni G, Labar B, Baron F, Cermak J, Bourhis JH, Storti G, Fazi P, Hagemeijer A, Vignetti M, Willemze R, de Witte T.

Bone Marrow Transplant. 2015 Mar;50(3):341-7. doi: 10.1038/bmt.2014.262. Epub 2014 Nov 17.

37.

Clear cell acanthoma on the dorsum of the hand.

Çetinözman F, Jansen P, Willemze R.

J Eur Acad Dermatol Venereol. 2016 Feb;30(2):378-80. doi: 10.1111/jdv.12811. Epub 2014 Oct 29. No abstract available.

PMID:
25353276
38.

Tumor-stage mycosis fungoides of the vulva successfully treated with local low-dose radiotherapy.

Bakar Ö, Şahin S, Çetinözman F, Willemze R, Tezcanli E, Çetin ED.

Dermatol Ther. 2015 Jan-Feb;28(1):36-9. doi: 10.1111/dth.12181. Epub 2014 Oct 14.

PMID:
25314306
39.

Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease.

Nicolae-Cristea AR, Benner MF, Zoutman WH, van Eijk R, Jansen PM, Tensen CP, Willemze R.

Br J Dermatol. 2015 Mar;172(3):784-8. doi: 10.1111/bjd.13476. Epub 2015 Jan 26. No abstract available.

PMID:
25308604
40.

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.

Oosterveld M, Suciu S, Muus P, Germing U, Delforge M, Belhabri A, Aul C, Selleslag D, Ferrant A, Marie JP, Amadori S, Jehn U, Mandelli F, Hess U, Hellström-Lindberg E, Cakmak-Wollgast S, Vignetti M, Labar B, Willemze R, de Witte T.

Ann Hematol. 2015 Jan;94(1):23-34. doi: 10.1007/s00277-014-2177-y. Epub 2014 Aug 7.

PMID:
25096636
41.

Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial.

Aslanyan MG, Kroeze LI, Langemeijer SM, Koorenhof-Scheele TN, Massop M, van Hoogen P, Stevens-Linders E, van de Locht LT, Tönnissen E, van der Heijden A, da Silva-Coelho P, Cilloni D, Saglio G, Marie JP, Tang R, Labar B, Amadori S, Muus P, Willemze R, Marijt EW, de Witte T, van der Reijden BA, Suciu S, Jansen JH.

Ann Hematol. 2014 Aug;93(8):1401-12. doi: 10.1007/s00277-014-2055-7. Epub 2014 Mar 29.

PMID:
24994606
42.

CD30-Negative Cutaneous T-Cell Lymphomas Other than Mycosis Fungoides.

Willemze R.

Surg Pathol Clin. 2014 Jun;7(2):229-52. doi: 10.1016/j.path.2014.02.006. Epub 2014 Apr 13. Review.

PMID:
26837200
43.

Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.

Koens L, Senff NJ, Vermeer MH, Willemze R, Jansen PM.

Am J Surg Pathol. 2014 Jul;38(7):999-1006. doi: 10.1097/PAS.0000000000000225.

PMID:
24805861
45.

Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma.

Çetinözman F, Jansen PM, Willemze R.

Br J Dermatol. 2014 Sep;171(3):499-504. doi: 10.1111/bjd.12934. Epub 2014 Aug 21.

PMID:
24601935
46.

Recent advances in primary cutaneous B-cell lymphomas.

Vermeer MH, Willemze R.

Curr Opin Oncol. 2014 Mar;26(2):230-6. doi: 10.1097/CCO.0000000000000060. Review.

PMID:
24463347
47.

Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop.

Robson A, Assaf C, Bagot M, Burg G, Calonje E, Castillo C, Cerroni L, Chimenti N, Dechelotte P, Franck F, Geerts M, Gellrich S, Goodlad J, Kempf W, Knobler R, Massone C, Meijer C, Ortiz P, Petrella T, Pimpinelli N, Roewert J, Russell-Jones R, Santucci M, Steinhoff M, Sterry W, Wechsler J, Whittaker S, Willemze R, Berti E.

Histopathology. 2015 Oct;67(4):425-41. doi: 10.1111/his.12371. Epub 2015 Feb 24.

PMID:
24438036
48.

MicroRNA profiling of primary cutaneous large B-cell lymphomas.

Koens L, Qin Y, Leung WY, Corver WE, Jansen PM, Willemze R, Vermeer MH, Tensen CP.

PLoS One. 2013 Dec 16;8(12):e82471. doi: 10.1371/journal.pone.0082471. eCollection 2013.

49.

Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.

Willemze R, Bradford RL, Mooberry MJ, Roubey RA, Key NS.

Thromb Res. 2014 Feb;133(2):187-9. doi: 10.1016/j.thromres.2013.11.027. Epub 2013 Dec 1.

50.

Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoides.

Boonk SE, Putter H, Koolhof L, Willemze R, Vermeer MH.

Br J Dermatol. 2014 May;170(5):1080-6. doi: 10.1111/bjd.12763.

PMID:
24299563

Supplemental Content

Loading ...
Support Center